EX-32.1 3 exhibit_32-1.htm EXHIBIT 32.2



EXHIBIT 32.1
 
CERTIFICATION OF CHIEF EXECUTIVE AND FINANCIAL OFFICERS
PURSUANT TO U.S.C. SEC. 1350

Each of the undersigned officers of Artemis Therapeutics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge:

 
(i)
That the Quarterly Report for the fiscal quarter ended March 31, 2019 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
(ii)
The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Date: May 15, 2019
/s/ Chanan Morris
 
 
By: Chanan Morris, Chief Financial Officer
(Principal Executive Officer, Principal Financial and Accounting Officer)